Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 06, 2018 05:00 ET | Source: Genetic Technologies Limited

Change of Chief Executive Officer

MELBOURNE, Australia, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”, “GTG”), advises that the Board and Mr Eutillio Buccilli have today agreed...
February 05, 2018 05:00 ET | Source: Genetic Technologies Limited

Appointment of Chairman

MELBOURNE, Australia, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”, “GTG”), is pleased to announce that the Board of Directors has appointed Dr...
January 31, 2018 05:00 ET | Source: Genetic Technologies Limited

Results from 31 January 2018 General Meeting

MELBOURNE, Australia, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”) advises that a General Meeting of shareholders that had been...
January 30, 2018 05:00 ET | Source: Genetic Technologies Limited

Resignation of Directors

MELBOURNE, Australia, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (Nasdaq:GENE) (“Company”), advises that Dr Malcolm R. Brandon and Mr Grahame Leonard, AM have resigned...
January 29, 2018 05:30 ET | Source: Genetic Technologies Limited

Genetic Technologies Limited: Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 31 December 2017

HIGHLIGHTS Completed a three month promotional campaign leading up to and throughout October Breast Cancer Awareness Month Ohio State University: patient recruitment for the collaborative clinical...
January 09, 2018 05:00 ET | Source: Genetic Technologies Limited

Genetic Technologies Regains Nasdaq Listing Compliance

MELBOURNE, Australia, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (Nasdaq:GENE) (“Company”), is pleased to advise that the Company received a notification letter (the...
December 12, 2017 05:00 ET | Source: Genetic Technologies Limited

Genetic Technologies Provides Update on Strategic Review Initiative

MELBOURNE, Australia, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”), a molecular diagnostics company focused on cancer risk assessment, and...
December 01, 2017 05:00 ET | Source: Genetic Technologies Limited

Notice Received Under Section 249D of the Corporations Act

MELBOURNE, Australia, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”), advises that on 29 November it received a notice under Section 249D of the...
October 30, 2017 05:00 ET | Source: Genetic Technologies Limited

Genetic Technologies Limited: Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 30 September 2017

HIGHLIGHTS Launched a three month promotional campaign leading up to and throughout October Breast Cancer Awareness Month BREVAGenplus commercial program to transition to an ecommerce based...
September 21, 2017 05:30 ET | Source: Genetic Technologies Limited

Genetic Technologies Transitions to Online Commercial Platform for BREVAGenplus®

MELBOURNE, Australia, Sept. 21, 2017 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”), a molecular diagnostics company specialising in cancer genomics, and...